Adipose tissue-derived stem cells in clinical applications

Expert Opinion on Biological Therapy

Volumn 13, Issue 10, 2013, Pages 1357-1370

  Pikuła, Michał ^a   Marek Trzonkowska, Natalia ^a   Wardowska, Anna ^a   Renkielska, Alicja ^a   Trzonkowski, Piotr ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Adipose tissue derived stem cells; Cell processing; Clinical application; Phenotype; Safety; Treatment outcome

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; BETA1 INTEGRIN; BIOLOGICAL MARKER; CD14 ANTIGEN; CD34 ANTIGEN; CD44V ANTIGEN; CD45 ANTIGEN; ENDOGLIN; EPIDERMAL GROWTH FACTOR; FIBRIN GLUE; FIBROBLAST GROWTH FACTOR 2; GAMMA INTERFERON; GLUTATHIONE PEROXIDASE; MYOSIN LIGHT CHAIN 2; REACTIVE OXYGEN METABOLITE; SCATTER FACTOR; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA; TROPONIN I; VASCULOTROPIN;

ADIPOSE DERIVED STEM CELL; AMYOTROPHIC LATERAL SCLEROSIS; ANUS FISTULA; APOPTOSIS; AVASCULAR NECROSIS; BONE GRAFT; BONE MARROW BIOPSY; BRAIN DAMAGE; BREAST AUGMENTATION; BREAST RECONSTRUCTION; BUERGER DISEASE; CANCER PATIENT; CARCINOGENESIS; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CELL FRACTIONATION; CELL ISOLATION; CELL THERAPY; CEREBROVASCULAR ACCIDENT; CHRONIC WOUND; CLINICAL TRIAL (TOPIC); CROHN DISEASE; ENTERITIS; ENTEROCUTANEOUS FISTULA; ENZYME ACTIVITY; EX VIVO STUDY; FOLLOW UP; FRAGILITY FRACTURE; GRAFT VERSUS HOST REACTION; HEART INFARCTION; HLA SYSTEM; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; INTERVERTEBRAL DISK DEGENERATION; KIDNEY FAILURE; LEG ISCHEMIA; LIVER CIRRHOSIS; MESENCHYMAL STEM CELL; MULTICENTER STUDY (TOPIC); MULTIPLE SCLEROSIS; MUSCULOSKELETAL DISEASE; NEUROLOGIC DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OSTEOARTHRITIS; OXIDATIVE STRESS; PARKINSON DISEASE; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 4 CLINICAL TRIAL (TOPIC); PHENOTYPE; PLASTIC SURGERY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGENERATIVE MEDICINE; REVIEW; RHEUMATOID ARTHRITIS; SKULL DEFECT; SPINAL CORD INJURY; STRESS INCONTINENCE; SYSTEMIC SCLEROSIS; TISSUE REGENERATION; ULCERATIVE COLITIS; UMBILICAL CORD BLOOD; URETHRA STRICTURE; URINARY TRACT DISEASE; URINE INCONTINENCE; WOUND HEALING;

ADIPOSE TISSUE; ANIMALS; HUMANS; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; STEM CELLS; TISSUE ENGINEERING;

EID: 84884238737     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.2013.823153     Document Type: Review

References (100)

1. Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng 2001;7:211-28
2. Zimmerlin L, Donnenberg VS, Pfeifer ME, et al. Stromal vascular progenitors in adult human adipose tissue. Cytometry A 2010;77:22-30
3. Strem BM, Hicok KC, Zhu M, et al. Multipotential differentiation of adipose tissue-derived stem cells. Keio J Med 2005;54:132-41
4. Gimble J, Guilak F. Adipose-derived adult stem cells: Isolation, characterization, and differentiation potential. Cytotherapy 2003;5:362-9
5. DiMuzio P, Tulenko T. Tissue engineering applications to vascular bypass graft development: The use of adipose-derived stem cells. J Vasc Surg 2007;44:A99-103
6. Auxenfans C, Lequeux C, Perrusel E, et al. Adipose-derived stem cells (ASCs) as a source of endothelial cells in the reconstruction of endothelialized skin equivalents. J Tissue Eng Regen Med 2012;6:512-51
7. Ashjian PH, Elbarbary AS, Edmonds B, et al. In vitro differentiation of human processed lipoaspirate cells into early neural progenitors. Plast Reconstr Surg 2003;111:1922-31
8. Kingham PJ, Kalbermatten DF, Mahay D, et al. Adipose-derived stem cells differentiate into a Schwann cell phenotype and promote neurite outgrowth in vitro. Exp Neurol 2007;207:267-74
9. Tomita K, Madurab T, Sakaia Y, et al. Glial differentiation of human adipose-derived stem cells: Implications for cell-based transplantation therapy. Neuroscience 2013;236:55-65
10. Seo MJ, Suh SY, Bae YC, Jung JS. Differentiation of human adipose stromal cells into hepatic lineage in vitro and in vivo. Biochem Biophys Res Commun 2005;328:258-64
11. Dhanasekaran M, Indumathi S, Harikrishnan R, et al. Human omentum fat-derived mesenchymal stem cells transdifferentiates into pancreatic islet-like cluster. Cell Biochem Funct 2013; published online 12 January 2013; doi: 10.1002/cbf.2948
12. Friedenstein AJ, Petrakova KV, Kurolesova AI, et al. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 1968;6:230-47
13. Caplan AI. Mesenchymal stem cells. J Orthop Res 1991;9:641-50
14. Deans RJ, Moseley AB. Mesenchymal stem cells: Biology and potential clinical uses. Exp Hematol 2000;28:875-84
15. Sanz-Ruiz R, Fernández-Santos E, Domínguez-Muñoa M, et al. Early translation of adipose-derived cell therapy for cardiovascular disease. Cell Transplant 2009;18:245-54
16. Young HE, Steele TA, Bray RA, et al. Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis derived from fetal, adult, and geriatric donors. Anat Rec 2001;264:51-62
17. Salingcarnboriboon R, Yoshitake H, Tsuji K, et al. Establishment of tendon-derived cell lines exhibiting pluripotent mesenchymal stem cell-like property. Exp Cell Res 2003;287:289-300
18. Fickert S, Fiedler J, Brenner RE. Identification of subpopulations with characteristics of mesenchymal progenitor cells from human osteoarthritic cartilage using triple staining for cell surface markers. Arthritis Res Ther 2004;6:R422-32
19. da Silva Meirelles L, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 2006;119:2204-13
20. Tang W, Zeve D, Suh JM, et al. White fat progenitor cells reside in the adipose vasculature. Science 2008;322:583-6
21. Traktuev DO, Merfeld-Clauss S, Li J, et al. A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks. Circ Res 2008;102:77-85
22. De Ugarte DA, Morizono K, Elbarbary A, et al. Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cell Tissues Organs 2003;174:101-9
23. Fang B, Song Y, Liao L, et al. Favorable response to human adipose tissue-derived mesenchymal stem cells in steroid-refractory acute graft-versus-host disease. Transplant Proc 2007;30:3358-62
24. Puissant B, Barreau C, Bourin P, et al. Immunomodulatory effect of human adipose tissue-derived adult stem cells: Comparison with bone marrow mesenchymal stem cells. Br J Haematol 2005;129:118-29
25. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8:315-17
26. Jarocha D, Lukasiewicz E, Majka M. Adventage of mesenchymal stem cells (MSC) expansion directly from purified bone marrow CD105+ and CD271+ cells. Folia Histochem Cytobiol 2008;46:307-14
27. Phinney DG, Prockop DJ. Concise review: Mesenchymal stem/multipotent stromal cells: The state of transdifferentiation and modes of tissue repair-current views. Stem Cells 2007;25:2896-902
28. Strioga M, Viswanathan S, Darinskas A, et al. Same or not the samëComparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells. Stem Cells Development 2012;21:2724-52
29. McIntosh KR, Lopez MJ, Borneman JN, et al. Immunogenicity of allogeneic adipose-derived stem cells in a rat spinal fusion model. Tissue Eng Part A 2009;15:2677-86
30. Hoogduijn MJ, Crop MJ, Peeters AM, et al. Human heart, spleen, and perirenal fat-derived mesenchymal stem cells have immunomodulatory capacities. Stem Cells Dev 2007;16:597-604
31. Mosna F, Sensebé L, Krampera M. Human bone marrow and adipose tissue mesenchymal stem cells: A user's guide. Stem Cells Dev 2010;10:1449-70
32. Krampera M, Cosmi L, Angeli R, et al. Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 2006;24:386-98
33. Cheng KH, Kuo TL, Kuo KK, Hsiao CC. Human adipose-derived stem cells: Isolation, characterization and current application in regeneration medicine. Genomic Medicine, Biomarkers, Health Sci 2011;3:53-62
34. Gaiba S, França LP, França JP, Ferreira LM. Characterization of human adipose-derived stem cells. Acta Cir Bras 2012;27:471-6
35. Yañez R, Lamana ML, García-Castro J, et al. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease. Stem Cells 2006;24:2582-91
36. Gronthos S, Franklin DM, Leddy HA, et al. Surface protein characterization of human adipose tissue-derived stromal cells. J Cell Physiol 2001;189:54-63
37. Rebelatto CK, Aguiar AM, Moretäo MP, et al. Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue. Exp Biol Med (Maywood) 2008;233:901-13
38. Suga H, Matsumoto D, Eto H, et al. Functional implications of CD34 expression in human adipose-derived stem/progenitor cells. Stem Cells Dev 2009;18:1201-10
39. Gimble JM, Katz AJ, Bunnell BA. Adipose-derived stem cells for regenerative medicine. Circ Res 2007;100:1249-60
40. Banfi A, Bianchi G, Galotto M, et al. Bone marrow stromal damage after chemo/radiotherapy: Occurrence, consequences and possibilities of treatment. Leuk Lymphoma 2001;42:863-70
41. Muschler GF, Nitto H, Boehm CA, Easley KA. Age- and gender-related changes in the cellularity of human bone marrow and the prevalence of osteoblastic progenitors. J Orthop Res 2001;19:117-25
42. Fraser JK, Schreiber RE, Zuk PA, Hedrick MH. Adult stem cell therapy for the heart. Int J Biochem Cell Biol 2004;36:658-66
43. Peng L, Jia Z, Yin X, et al. Comparative analysis of mesenchymal stem cells from bone marrow, cartilage, and adipose tissue. Stem Cells Dev 2008;17:761-73
44. Garcia-Olmo D, Herreros D, Pascual M, et al. Treatment of enterocutaneous fistula in Crohn's Disease with adipose-derived stem cells: A comparison of protocols with and without cell expansion. Int J Colorectal Dis 2009;24:27-30
45. Lendeckel S, Jödicke A, Christophis P, et al. Autologous stem cells (adipose) and fibrin glue used to treat widespread traumatic calvarial defects: Case report. J Craniomaxillofac Surg 2004;32:370-3
46. Kern S, Eichler H, Stoeve J, et al. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 2006;24:1294-301
47. Al Battah F, De Kock J, Ramboer E, et al. Evaluation of the multipotent character of human adipose tissue-derived stem cells isolated by Ficoll gradient centrifugation and red blood cell lysis treatment. Toxicol In Vitro 2011;25:1224-30
48. Dhanasekaran M, Indumathi S, Rajkumar S, et al. Characterization of human adipose tissue derived hematopoietic stem cell, mesenchymal stem cell and side population cells. Int J Biol 2010;2:71-8
49. Lin K, Matsubara Y, Masuda Y, et al. Characterization of adipose tissue-derived cells isolated with the Celution system. Cytotherapy 2008;10:417-26
50. Yamamoto T, Gotoh M, Kato M, et al. Periurethral injection of autologous adipose-derived regenerative cells for the treatment of male stress urinary incontinence: Report of three initial cases. Int J Urol 2012;19:652-9
51. Yoshimura K, Sato K, Aoi N, et al. Cell-assisted lipotransfer for cosmetic breast augmentation: Supportive use of adipose-derived stem/stromal cells. Aesthetic Plast Surg 2008;32:48-55; discussion 56-7
52. McIntosh K, Zvonic S, Garrett S, et al. The immunogenicity of human adipose-derived cells: Temporal changes in vitro. Stem Cells 2006;24:1246-53
53. Di Bella C, Farlie P, Penington AJ. Bone regeneration in a rabbit critical-sized skull defect using autologous adipose-derived cells. Tissue Eng Part A 2008;14:483-90
54. Bodle JC, Hanson AD, Loboa EG. Adipose-derived stem cells in functional bone tissue engineering: Lessons from bone mechanobiology. Tissue Eng Part B Rev 2011;17:195-211
55. Mizuno H, Zuk PA, Zhu M, et al. Myogenic differentiation by human processed lipoaspirate cells. Plast Reconstr Surg 2002;109:199-209. discussion 210-11
56. Wu L, Cai X, Zhang S, et al. Regeneration of articular cartilage by adipose tissue derived mesenchymal stem cells: Perspectives from stem cell biology and molecular medicine. J Cell Physiol 2013;228:938-44
57. Manning CN, Schwartz AG, Liu W, et al. Controlled delivery of mesenchymal stem cells and growth factors using a nanofiber scaffold for tendon repair. Acta Biomater 2013; published online 13 February 2013; doi: 10.1016/j. actbio.2013.02.008
58. Caprilli R, Gassull MA, Escher JC, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: Special situations. Gut 2006;55:i36-50
59. García-Olmo D, García-Arranz M, Herreros D, et al. A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum 2005;48:1416-23
60. Garcia-Olmo D, Herreros D, Pascual I, et al. Expanded adipose-derived stem cells for the treatment of complex perianal fistula: A phase II clinical trial. Dis Colon Rectum 2009;52:79-86
61. Song YH, Gehmert S, Sadat S, et al. VEGF is critical for spontaneous differentiation of stem cells into cardiomyocytes. Biochem Biophys Res Commun 2007;354:999-1003
62. Planat-Bénard V, Menard C, André M, et al. Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circ Res 2004;96:223-9
63. Choi YS, Dusting GJ, Stubbs et al. Differentiation of human adipose-derived stem cells into beating cardiomyocytes. J Cell Mol Med 2010;14:878-89
64. Yang J, Zhang H, Zhao L, et al. Human adipose tissue-derived stem cells protect impaired cardiomyocytes from hypoxia/ reoxygenation injury through hypoxia-induced paracrine mechanism. Cell Biochem Funct 2012;30:505-14
65. Bai X, Alt E. Myocardial regeneration potential of adipose tissue-derived stem cells. Biochem Biophys Res Commun 2010;401:321-6
66. Danoviz ME, Nakamuta JS, Marques FL, et al. Rat adipose tissue-derived stem cells transplantation attenuates cardiac dysfunction post infarction and biopolymers enhance cell retention. PLoS ONE 2010;5:e12077
67. Valina C, Pinkernell K, Song YH, et al. Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction. Eur Heart J 2007;28:2667-777
68. Zhu XY, Zhang XZ, Xu L, et al. Transplantation of adipose-derived stem cells overexpressing hHGF into cardiac tissue. Biochem Biophys Res Commun 2009;379:1084-90
69. Cai L, Johnstone BH, Cook TG, et al. IFATS collection: Human adipose tissue-derived stem cells induce angiogenesis and nerve sprouting following myocardial infarction, in conjunction with potent preservation of cardiac function. Stem Cells 2009;27:230-7
70. Baer PC, Geiger H. Adipose-derived mesenchymal stromal/stem cells: Tissue localization, characterization, and heterogeneity. Stem Cells Int 2012; published online 12 April 2012; doi: 10.1155/2012/812693
71. Chandler EM, Seo BR, Califano JP, et al. Implanted adipose progenitor cells as physicochemical regulators of breast cancer. Proc Natl Acad Sci USA 2012;109:9786-91
72. Zavan B, Vindigni V, Gardin C, et al. Neural potential of adipose stem cells. Discov Med 2010;10:37-43
73. Kang SK, Lee DH, Bae YC, et al. Improvement of neurological deficits by intracerebral transplantation of human adipose tissue-derived stromal cells after cerebral ischemia in rats. Exp Neurol 2003;182:355-66
74. Mustoe T. Understanding chronic wounds: A unifying hypothesis on their pathogenesis and implications for therapy. Am J Surg 2004;187:65S-70S
75. Simka M, Majewski E. The social and economic burden of venous leg ulcers: Focus on the role of micronized purified flavonoid fraction adjuvant therapy. Am J Clin Dermatol 2003;4:573-81
76. Lau K, Paus R, Tiede S, et al. Exploring the role of stem cells in cutaneous wound healing. Exp Dermatol 2009;18:921-33
77. Pikuła M, Trzonkowski P. Biology of epidermal stem cells: Impact on medicine. Postepy Hig Med Dosw 2009;15:449-56
78. Ebrahimian TG, Pouzoulet F, Squiban C, et al. Cell therapy based on adipose tissue-derived stromal cells promotes physiological and pathological wound healing. Arterioscler Thromb Vasc Biol 2009;29:503-10
79. Cherubino M, Rubin JP, Miljkovic N, et al. Adipose-derived stem cells for wound healing applications. Ann Plast Surg 2011;66:210-15
80. Du Y, Roh DS, Funderburgh ML, et al. Adipose-derived stem cells differentiate to keratocytes in vitro. Mol Vis 2010;16:2680-9
81. Trottier V, Marceau-Fortier G, Germain L, et al. IFATS collection: Using human adipose-derived stem/ stromal cells for the production of new skin substitutes. Stem Cells 2008;26:2713-23
82. Rigotti G, Marchi A, Galiè M, et al. Clinical treatment of radiotherapy tissue damage by lipoaspirate transplant: A healing process mediated by adipose-derived adult stem cells. Plast Reconstr Surg 2007;119:1409-22; discussion 1423-4
83. Kim WS, Park BS, Sung JH, et al. Wound healing effect of adipose-derived stem cells: A critical role of secretory factors on human dermal fibroblasts. J Dermatol Sci 2007;48:15-24
84. Song SY, Jung JE, Jeon YR, et al. Determination of adipose-derived stem cell application on photo-aged fibroblasts, based on paracrine function. Cytotherapy 2011;13:378-84
85. Deveza L, Choi J, Imanbayev G, Yang F. Paracrine release from nonviral engineered adipose-derived stem cells promotes endothelial cell survival and migration in vitro. Stem Cells Dev 2013;22:483-91
86. Jee MK, Im YB, Choi JI, Kang SK. Compensation of cATSCs-derived TGFb1 and IL10 expressions was effectively modulated atopic dermatitis. Cell Death Differ 2013; published online 14 February 2013; doi: 10.1038/ cddis.2013.4
87. Kim WS, Park BS, Sung JH. The wound- healing and antioxidant effects of adipose-derived stem cells. Expert Opin Biol Ther 2009;9:879-87
88. Kim WS, Park BS, Kim HK, et al. Evidence supporting antioxidant action of adipose-derived stem cells: Protection of human dermal fibroblasts from oxidative stress. J Dermatol Sci 2008;49:133-42
89. Kakudo N, Minakata T, Mitsui T, et al. Proliferation-promoting effect of platelet-rich plasma on human adipose-derived stem cells and human dermal fibroblasts. Plast Reconstr Surg 2008;122:1352-60
90. Vermette M, Trottier V, Ménard V, et al. Production of a new tissue-engineered adipose substitute from human adipose-derived stromal cells. Biomaterials 2007;28:2850-60
91. Di Nicola M, Carlo-Stella C, Magni M, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002;99:3838-43
92. Maitra B, Szekely E, Gjini K, et al. Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant 2004;33:597-604
93. Bartholomew A, Sturgeon C, Siatskas M, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002;30:42-8
94. Le Blanc K, Tammik C, Rosendahl K, et al. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 2003;31:890-6
95. Lazarus HM, Koc ON, Devine SM, et al. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 2005;11:389-98
96. Le Blanc K, Rasmusson I, Sundberg B, et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004;363:1439-41
97. Le Blanc K, Frassoni F, Ball L, et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: A phase II study. Lancet 2008;371:1579-86
98. Keyser KA, Beagles KE, Kiem HP. Comparison of mesenchymal stem cells from different tissues to suppress T-cell activation. Cell Transplant 2007;16:555-62
99. Marek-Trzonkowska N, Mys'liwec M, Siebert J, Trzonkowski P. Clinical application of regulatory T cells in type 1 diabetes. Pediatr Diabetes 2013; published online 30 April 2013; doi: 10.1111/pedi.12029
100. Marek N, Bieniaszewska M, Krzystyniak A, et al. The time is crucial for ex vivo expansion of T regulatory cells for therapy. Cell Transplant 2011;20:1747-58